Related Experiment Video
Updated: Jul 6, 2026

09:35
Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Hepatitis G virus: a suitable marker of in vivo efficacy for pathogen inactivation
J-J Lefrère1, S Laperche, F Roudot-Thoraval
1Department of Blood-Transmissible Agents, National Institute of Blood Transfusion, Paris, France. jeanjacqueslefrere@orange.fr
Vox Sanguinis
|April 9, 2008
Abstract:
Being an orphan virus despite a large number of investigations, hepatitis G virus is a blood-borne agent for which screening is not required in blood donations. The in vivo efficacy of pathogen inactivation methods could be assessed by the absence of hepatitis G virus markers after transfusion of pathogen-inactivated blood products, in recipients susceptible to infection before the transfusion.
